Mri 1 5T Firmware CVE-2021-42744

Q: What is the CVSS score of CVE-2021-42744?

CVE-2021-42744 has a CVSS 4.0 base score of 5.9 (Medium). CVSS vector: CVSS:4.0/AV:L/AC:L/AT:P/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X. EPSS exploitation probability: 0.0%.

MEDIUM

Files or Directories Accessible to External Parties (CWE-552)

2021-11-19 20705f08-db8b-4497-8f94-7eea62317651

Information Disclosure Path Traversal Mri 1 5T Firmware Mri 3T Firmware

5.9

CVSS 4.0 · NVD

Severity by source

NVD PRIMARY

5.9 MEDIUM

CVSS:4.0/AV:L/AC:L/AT:P/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:4.0/AV:L/AC:L/AT:P/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Attack Vector

Local

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Lifecycle Timeline

CVE Published

Nov 19, 2021 - 19:15 nvd

MEDIUM 5.9

DescriptionCVE.org

Philips MRI 1.5T and MRI 3T Version 5.3 through 5.8.1 does not restrict or incorrectly restricts access to a resource from an unauthorized actor.

AnalysisAI

Philips MRI 1.5T and MRI 3T Version 5.3 through 5.8.1 does not restrict or incorrectly restricts access to a resource from an unauthorized actor. Rated medium severity (CVSS 5.9), this vulnerability is no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-552. Philips MRI 1.5T and MRI 3T Version 5.3 through 5.8.1 does not restrict or incorrectly restricts access to a resource from an unauthorized actor. Affected products include: Philips Mri 1.5T Firmware, Philips Mri 3T Firmware. Version information: Version 5.3.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.